CL
JAZZ icon

Choreo LLC’s Jazz Pharmaceuticals JAZZ Stock Holding History

Choreo LLC’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$734K Buy
3,045
+77
+3% +$16.9K 0.01% 790
2026
Q1 		$561K Buy
2,968
+85
+3% +$14.9K 0.01% 875
2025
Q4 		$492K Buy
+2,883
New +$442K 0.01% 930
2025
Q2 		– Sell
-2,423
Closed -$301K – 1567
2025
Q1 		$301K Sell
2,423
-531
-18% -$69.3K ﹤0.01% 1087
2024
Q4 		$363K Buy
2,954
+1,087
+58% +$128K 0.01% 1076
2024
Q3 		$204K Buy
+1,867
New +$205K ﹤0.01% 1460

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Choreo LLC's JAZZ Position: Q2 2026 in Review

Choreo LLC increased its Jazz Pharmaceuticals (JAZZ) stake by 2.6% in Q2 2026, buying an estimated $16.9K and bringing the position to 3,045 shares worth $734K. The position accounts for 0.01% of the portfolio, ranked #790.

Choreo LLC first reported a position in JAZZ in Q3 2024 and has held it in 6 quarters since. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Choreo LLC held 3,045 shares of Jazz Pharmaceuticals worth $734K as of Q2 2026.
  • Choreo LLC bought 77 Jazz Pharmaceuticals shares in Q2 2026, an estimated $16.9K.
  • Jazz Pharmaceuticals made up 0.01% of Choreo LLC's portfolio in Q2 2026, its #790 holding.
  • Choreo LLC first reported a position in Jazz Pharmaceuticals in Q3 2024 and has held it in 6 quarters since.
  • 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Choreo LLC's 13F filing for Q2 2026, filed 4 Aug 2026.